|
Tabla 1: Características de la muestra de estudio y su asociación con lesión renal aguda (LRA). |
||||
|
Característica |
Total (N = 98) n (%) |
LRA (N = 39) n (%) |
Sin LRA (N = 59) n (%) |
RM (IC95%) |
|
Edad [años]* |
61.5 ± 18.0 |
67.2 ± 16.9 |
57.8 ± 16.9 |
1.03 (1.01-1.06) |
|
Sexo |
||||
|
Masculino |
53 (54.1) |
24 (61.5) |
29 (49.2) |
1.25 (0.85-1.65) |
|
Femenino |
45 (45.9) |
15 (38.5) |
30 (50.8) |
0.60 (0.27-1.38) |
|
Comorbilidades |
||||
|
Diabetes mellitus |
14 (14.29) |
7 (18.0) |
7 (11.9) |
1.63 (0.52-5.06) |
|
Hipertensión arterial |
28 (28.6) |
14 (35.9) |
14 (23.8) |
1.80 (0.74-4.37) |
|
EPOC |
5 (5.1) |
3 (7.7) |
2 (3.4) |
2.38 (0.38-14.91) |
|
Cáncer |
12 (12.2) |
4 (10.3) |
8 (13.4) |
0.73 (0.20-2.61) |
|
Cirrosis |
2 (2.0) |
1 (2.6) |
2 (1.7) |
1.53 (0.09-25.15) |
|
Insuficiencia cardiaca |
2 (2.0) |
2 (5.1) |
0 (0.0) |
– |
|
Infarto agudo del miocardio |
7 (7.1) |
4 (10.3) |
3 (5.1) |
2.13 (0.45-10.11) |
|
Fibrilación auricular |
9 (9.2) |
6 (15.4) |
3 (5.1) |
3.39 (0.80-14.50) |
|
Neumonía |
||||
|
COVID |
36 (36.7) |
11 (28.2) |
25 (42.4) |
1 |
|
No COVID |
62 (63.3) |
28 (71.8) |
34 (57.6) |
1.87 (0.78-4.46) |
|
Creatinina (mg/dL), p50 [p25, p75] |
||||
|
Ingreso |
0.77 [0.65, 0.95] |
0.86 [0.65, 0.98] |
0.74 [0.61, 0.90] |
3.07 [0.36, 25.95] |
|
48 horas |
0.90 [0.72, 1.16] |
1.22 [0.98, 1.56] |
0.76 [0.61, 0.87] |
1,208.95 [66.92, 21,840.76] |
|
72 horas |
0.90 [0.71, 1.18] |
1.23 [1.05, 1.43] |
0.78 [0.62, 0.90] |
3,848.91 [132.08, 112,155.80] |
|
Tasa de filtración glomerular (mL/min/1.73 m2)* |
87.6 ± 26.8 |
74.6 ± 29.6 |
96.2 ± 20.8 |
0.97 (0.95-0.98) |
|
Interleucina 6 (pg/mL), p50 [p25, p75] |
42.9 [15.6, 109.7] |
47.4 [17.6, 173.0] |
35.9 [15.0, 89.5] |
1.0004 [0.999, 1.001] |
|
EPOC = enfermedad pulmonar obstructiva crónica. RM = razón de momios. IC95% = intervalo de confianza al 95%. Los números en negrita corresponden a razones de momios cuyos intervalos de confianza no cruzan el valor nulo = 1. * Valores expresados en media ± desviación estándar. |
||||